Log In
Join
28th March 2024
07:00
Hutchmed China Ltd - Savolitinib sNDA Accepted in China
22nd March 2024
07:00
Hutchmed China Ltd - Initiation of Registration Stage of P2/3 Trial
14th March 2024
09:00
Hutchmed China Ltd - LTIP and Share Option Scheme
5th March 2024
08:30
Hutchmed China Ltd - Vesting of awards under the LTIP
28th February 2024
12:45
Hutchmed China Ltd - Publication of Form 20-F
28th February 2024
11:30
Hutchmed China Ltd - 2023 Full Year Results and Business Updates
7th February 2024
07:00
Hutchmed China Ltd - Presentation of Phase III Data on Fruquintinib
2nd February 2024
08:37
Hutchmed China Ltd - Inmagene Exercises Option for Two Drug Candidates
1st February 2024
08:30
Hutchmed China Ltd - HUTCHMED to Announce 2023 Final Results
30th January 2024
07:12
Hutchmed China Ltd - HUTCHMED Receives Marketing Approval in Hong Kong
11th January 2024
07:00
Hutchmed China Ltd - Sovleplenib NDA Granted Priority Review in China
29th December 2023
08:30
Hutchmed China Ltd - Total Voting Rights
29th December 2023
08:30
Hutchmed China Ltd - Blocklisting Six Monthly Return
21st December 2023
10:00
Hutchmed China Ltd - Overseas Regulatory Announcement
13th December 2023
07:00
Hutchmed China Ltd - Completed Enrollment of Phase II/III Trial
13th December 2023
07:00
Hutchmed China Ltd - Inclusion in National Reimbursement Drug List
7th December 2023
10:04
Hutchmed China Ltd - Overseas Regulatory Announcement
1st December 2023
07:00
Hutchmed China Ltd - Clinical Data to be Presented at Congresses
Load more
HUTCHMED (China) Limited (HCM.L)
Share Price & News
Follow
Unfollow
Price Snapshot
Last Trades
Bid
-
-
-
Ask
High
-
OPEN
-
VOL
-
MKT CAP
-M
LOW
-
CLOSE
-
SHARES IN ISSUE
871.04M
Profile
Financials
RNS
Chart
Media
Board & Advisors
More...
HUTCHMED (China) Limited RNS
Watchlist